Activate Now
 
ProHealth me-cfs Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

The Exercise Intolerance in POTS, ME/CFS and Fibromyalgia Explained?

#ISpeakForPain Blitz

5 Ways That I Reduce Stress During Tough Times

Move More: How I Actually Started Exercising with a Chronic Condition

GUIDELINES FOR PAIN WARRIORS

8 Things to Consider for Depression

VIDEO: Living with Chronic Pain

ACTION ALERT: Improve US chronic pain care

Genes Highlight Inflammation and Mast Cells in Fibromyalgia

Moving Forward When a Treatment Proves Unsuccessful

 
Print Page
Email Article

Watch FDA's public review of Ampligen for ME/CFS, online Dec 20

  [ 8 votes ]   [ 1 Comment ]
www.ProHealth.com • December 7, 2012


Midnight Dec 6 was the deadline for patient submission of comments to be considered in the FDA's Dec 20 public review of Ampligen for potential approval as an Rx treatment for ME/CFS.

Now, patients & advocates are invited to view the live webcast of this public review on Dec 20, 8 am to 5 pm Eastern time. Oral testimony is scheduled for approximately 1 pm to 2:30 pm Eastern time.

The FDA has indicated it will post details, including the web address for the webcast and background material for the meeting, sometime on Dec 18 at this FDA site: http://www.fda.gov/AdvisoryCommittees/Calendar/ucm324972.htm.

The FDA also plans to post the webcast in its archive for later viewing.




Post a Comment

Featured Products From the ProHealth Store
MitoQ® Hydroxocobalamin Extreme™ Mitochondria Ignite™ with NT Factor®

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products


Article Comments Post a Comment

Testinonies for FDA meeting
Posted by: pokeydna
Dec 8, 2012
Patients wanting to send in their comments or testimony can send it to me Bob Miller
At 511bobmiller42@gmail.com and I will present it along with my testimony at the FDA meeting on December 20th. As always we appreciate the support from ProHealth
to the ME/CFS community.

Thank you Rick Carson,

Bob Miller
Reply Reply
 
Natural Pain Relief Supplements

Featured Products

MitoQ® MitoQ®
Powerful Antioxidant Support to Mitochondria
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Hydroxocobalamin Extreme™ Hydroxocobalamin Extreme™
The B-12 Your Brain Needs for Detox & Sharpness
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%

Natural Remedies

Natural Relief for Soreness, Pain and Swelling – Putting Out the Fire
Carry a Massage Therapist in Your Pocket Carry a Massage Therapist in Your Pocket
How I Found My Long-Lost Energy How I Found My Long-Lost Energy
Clinically Studied Joint Relief Product for FM & ME/CFS Clinically Studied Joint Relief Product for FM & ME/CFS
Pioneer Scientists Uncover a Revolutionary Neuroprotective Supplement for Nerve Health Pioneer Scientists Uncover a Revolutionary Neuroprotective Supplement for Nerve Health

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE AND SAVE 15% NOW*
Be the first to know about new products, special discounts and the latest health news. *New subscribers only

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2016 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map